1. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. Issue 10366 (26th November 2022) Authors: Li, Yi; Liang, Zhenyang; Qin, Lei; Wang, Mian; Wang, Xianzhao; Zhang, Huanyi; Liu, Yin; Li, Yan; Jia, Zhisheng; Liu, Limin; Zhang, Hongyan; Luo, Jun; Dong, Songwu; Guo, Jincheng; Zhu, Hengqing; Li, Shengli; Zheng, Haijun; Liu, Lijun; Wu, Yanqing; Zhong, Yiming Journal: Lancet Issue: Volume 400:Issue 10366(2022) Page Start: 1847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BRIGHT-4 trial: bivalirudin strikes back – Authors' reply. Issue 10383 (8th April 2023) Authors: Li, Yi; Liang, Zhenyang; Stone, Gregg W; Han, Yaling Journal: Lancet Issue: Volume 401:Issue 10383(2023) Page Start: 1158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability. Issue 6 (June 2015) Authors: Zhang, Xiaolin; Feng, Xueyao; Cai, Wenzhi; Liu, Tengfei; Liang, Zhenyang; Sun, Ying; Yan, Chenghui; Han, Yaling Journal: Thrombosis research Issue: Volume 135:Issue 6(2015) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of postprocedural full‐dose infusion of bivalirudin on acute stent thrombosis in patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real‐world population. Issue 3 (June 2017) Authors: Wang, Heyang; Liang, Zhenyang; Li, Yi; Li, Bin; Liu, Junming; Hong, Xueyi; Lu, Xin; Wu, Jiansheng; Zhao, Wei; Liu, Qiang; An, Jian; Li, Linfeng; Pu, Fanli; Ming, Qiang; Han, Yaling Journal: Cardiovascular therapeutics Issue: Volume 35:Issue 3(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial. Issue 7 (28th September 2016) Authors: Wang, Heyang; Li, Yi; Cong, Hongliang; Ding, Shifang; Liu, Bin; Li, Lu; Chen, Yundai; Jia, Shaobin; Jing, Quanmin; Zhao, Xin; Liu, Haiwei; Liang, Zhenyang; Li, Jing; Bao, Dan; Han, Yaling Journal: Catheterization and cardiovascular interventions Issue: Volume 89:Issue 7(2017) Page Start: 1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: The BRIGHT-4 Trial. Issue 4 (23rd August 2022) Authors: Liang, Zhenyang; Li, Yi; Stone, Gregg W.; Han, Yaling Journal: Cardiology discovery Issue: Volume 2:Issue 4(2022) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial. (13th January 2016) Authors: Liang, Zhenyang; Li, Yi; Wang, Jingping; Wang, Dongmei; Wang, Shouli; Ma, Likun; Liu, Huiliang; Yang, Lixia; Stone, Gregg W.; Han, Yaling Journal: Catheterization and cardiovascular interventions Issue: Volume 87(2016)Supplement 1 Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗